A687V EZH2 is a gain-of-function mutation found in lymphoma patients.

  title={A687V EZH2 is a gain-of-function mutation found in lymphoma patients.},
  author={Christina R A Majer and Lei Jin and Margaret Porter Scott and Sarah K. Knutson and Kevin W. Kuntz and Heike Keilhack and Jesse J Smith and Mikel P. Moyer and Victoria M. Richon and Robert A Copeland and Tim J. Wigle},
  journal={FEBS letters},
  volume={586 19},
Heterozygous point mutations at Y641 and A677 in the EZH2 SET domain are prevalent in about 10-24% of Non-Hodgkin lymphomas (NHL). Previous studies indicate that these are gain-of-function mutations leading to the hypertrimethylation of H3K27. These EZH2 mutations may drive the proliferation of lymphoma and make EZH2 a molecular target for patients harboring these mutations. Here, another EZH2 SET domain point mutation, A687V, occurring in about 1-2% of lymphoma patients, is also shown to be a… CONTINUE READING
45 Citations
25 References
Similar Papers


Publications citing this paper.
Showing 1-10 of 45 extracted citations


Publications referenced by this paper.
Showing 1-10 of 25 references

Similar Papers

Loading similar papers…